semaglutide and epilepsy A preliminary study of people with diabetes suggests that use of glucose-lowering GLP-1 drugs may be linked to a lower risk of developing epilepsy. The study was published on December 10, 2025 GLP-1s May Reduce Epilepsy Risk

Hormonal fluctuations: Given DSIP's effects on LH and GH, some hormonal variability is possible, though rarely problematic in documented use

Because they bundle coaching, medical access, and medication into a single high-tier plan, their GLP-1 pricing ranges from $498 to $998 per month, depending on whether you receive compounded semaglutide or brand-name Wegovy

Microdosing during titration adds complexity and makes it harder to assess tolerance

2025;12:e2417712

"L-Carnitine Supplementation for the Management of Fatigue in Patients With Cancer: An Eastern Cooperative Oncology Group Phase III, Randomized, Double-Blind, Placebo-Controlled Trial." J Clin Oncol 30(31): 3864-3869